Skip to main
DOCS

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 21 analyst ratings
Hold
Strong Buy 19%
Buy 24%
Hold 48%
Sell 10%
Strong Sell 0%

Bulls say

Doximity is a unique and valuable platform for physicians and other healthcare professionals, offering digital solutions for collaboration, career management, and virtual patient visits. The company's strong customer renewal rates and potential for expansion in existing accounts reflect the value of their services and the high level of satisfaction among its customers. The recent growth in AI search and AI scribe products further demonstrate the potential for increased revenue and retention as healthcare continues to shift towards digital solutions. While investments in AI may temporarily impact margins, the long-term potential for growth and market expansion make Doximity's stock a promising investment opportunity for those with a positive outlook.

Bears say

Doximity is expected to face challenges in its growth due to constraints in pharma budgets and increasing competition in their AI search and scribe products. The company's conservative approach in forecasting for the upcoming year adds to the negative outlook, with a lowered PT to $27. Although the company has strong margins and free cash flow, these may not be enough to offset slower growth and challenges in member engagement, particularly in a market with growing competition and budget constraints.

Doximity (DOCS) has been analyzed by 21 analysts, with a consensus rating of Hold. 19% of analysts recommend a Strong Buy, 24% recommend Buy, 48% suggest Holding, 10% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Hold based on their latest research and market trends.

According to 21 analysts, Doximity (DOCS) has a Hold consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $30.81, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $30.81, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.